|Founded||New York City, United States|
|Brian S. Tyler (CEO)|
|Revenue||US$263.97 billion (2022): 70|
|US$1.29 billion (2022): 70|
|US$1.29 billion (2022): 70|
|Total assets||US$63.30 billion (2022): 72|
|Total equity||US$1.79 billion (2022): 72|
Number of employees
|c. 75,000 (2022): 9|
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021.
McKesson is based in Irving, Texas, and distributes health care systems, medical supplies and pharmaceutical products. Additionally, McKesson provides extensive network infrastructure for the health care industry; also, it was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit of profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson has expanded on its well-established credentials as key vaccine distributor, serving as the U.S. government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over 1 billion doses across the United States.
Founded in New York City as Charles M. Olcott in 1828 and later as Olcott, McKesson & Co. by Charles Olcott and John McKesson in 1833, the business began as an importer and wholesaler of botanical drugs.
A third partner, Daniel Robbins, who had joined the enterprise as it grew, and who previously "was an assistant to the original partners," was the Robbins when the company was renamed McKesson & Robbins following Olcott's death in 1853.
The company successfully emerged from the fraud by CEO Phillip Musica one of the most notorious business/accounting scandals of the 20th century—the McKesson & Robbins scandal, a watershed event that led to major changes in American auditing standards and securities regulations after being exposed in 1938.
In 1967, Foremost Dairies, a company founded by James Cash Penney that had been headquartered in San Francisco since 1954, acquired McKesson & Robbins in a hostile takeover to form Foremost-McKesson Inc. The Foremost dairy operations were sold in 1982 and the name changed to McKesson Corporation but headquarters remained in San Francisco.
In 1999, McKesson acquired medical information systems firm HBO & Company (HBOC). The combined firm operated as McKessonHBOC for two years. Accounting irregularities at HBOC reduced the company's share price by half, and resulted in the dismissal and prosecution of many HBOC executives. The firm's name reverted to "McKesson" in 2001. McKesson has increased its market in medical technology through acquisitions, including Per Se Technologies and RelayHealth in 2006 and Practice Partner in 2007.
In 2010, McKesson acquired the oncology and physician services company US Oncology, Inc. for $2.16 billion, which was integrated into the McKesson Specialty Health business.
On June 24, 2013, The Wall Street Journal reported that McKesson Chairman and CEO John Hammergren's pension benefits of $159 million had set a record for "the largest pension on file for a current executive of a public company, and almost certainly the largest ever in corporate America".
In addition to its offices throughout North America, McKesson also has international offices in Australia, Ireland, France, the Netherlands, and the United Kingdom. Today, McKesson is one of the oldest operating businesses in the United States.
In 2017, McKesson was involved in a number of lawsuits against the state of Arkansas over the supply of vecuronium bromide. McKesson was under contract by Pfizer not to sell to any correctional facility that authorized and carried out Capital punishment.
In February 2020, McKesson Corp announced that it would part ways with Change Healthcare. McKesson would give up its three seats on Change's board of directors, and as an entity will no longer own any portion of Change.
In August 2020 during the COVID-19 pandemic, the CDC and HHS selected McKesson as the U.S. government's centralized distributor for Covid-19 vaccine doses and ancillary supply kits under Operation Warp Speed. As of May 5, 2022, McKesson had distributed over 380 million vaccine doses and assembled supply kits to support over 1.2 billion vaccines doses as of July 31, 2021. See Covid-19 Centralized Vaccine Distributor.
For the fiscal year 2018, McKesson reported earnings of US$67 million, with an annual revenue of US$208.357 billion, an increase of 5.0% over the previous fiscal cycle. McKesson's shares traded at over $142 per share, and its market capitalization was valued at over US$24.3 billion in October 2018. As of 2018, McKesson was ranked #6 on the Fortune 500 rankings of the largest United States corporations by total revenue.
|Price per share
McKesson Provider Technologies
McKesson Provider Technologies is the retail name for McKesson Technology Solutions; the software development division of McKesson. Their customer base in the United States includes 50% of all health systems, 20% of all physician practices, 25% of home care agencies, and 77% of health systems with more than 200 beds.
On June 20, 2005, McKesson Provider Technologies acquired Medcon, Ltd., an Israeli company which provides Web-based cardiac image and information management solutions for heart centers, that includes: diagnostic digital image management, archiving, procedure reporting, and workflow management.
McKesson Medical Supplies and Equipment
McKesson Medical-Surgical (MMS) offers a large selection of national health care brands, along with McKesson's exclusive brand of medical products.
Their online medical supply ordering platform serves the needs of physician offices, surgery centers, home health agencies, DMEs, labs, and long-term-care facilities.
Health Mart pharmacy franchise
Health Mart is a network of over 4,000 independently owned and operated pharmacies. It is a wholly owned subsidiary of McKesson Corporation, which owns the name "Health Mart". McKesson acquired Health Mart owner FoxMeyer in October 1996.
McKesson operated the Mosswood Wine Company from 1978 until 1987, when the division was sold to maintain their focus on pharmaceuticals. The division was founded and run by wine writer Gerald Asher.
NDC (from the initials of its former identity as National Data Corporation) became NDC-Health Corp in 2001.
National Data Corporation
National Data Corporation was a time-sharing company that began in 1967 and subsequently absorbed competitor Rapidata. Rapidata held on, and became part of National Data Corporation. It was still of sufficient interest in 1982 to be the focus of "A User's Guide to Statistics Programs: The Rapidata Timesharing System". Even as revenue fell by 66% and National Data subsequently developed its own problems, attempts were made to keep this timesharing business going.
Rapidata was listed in The AUERBACH Guide to Time Sharing in 1973.
In 2008, McKesson paid $13 million in fines for failing to report huge orders of hydrocodone. In January 2017, McKesson agreed to pay a $150 million civil penalty for alleged similar violations of the Controlled Substances Act regarding the distribution of opioids.
In May 2020, Oklahoma Attorney General Mike Hunter sued McKesson in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and AmerisourceBergen, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."
In January 2022, McKesson, AmerisourceBergen, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties.
Covid-19 Centralized Vaccine Distributor
In August 2020 during the COVID-19 pandemic, the CDC and HHS selected McKesson as the U.S. government's centralized distributor for Covid-19 vaccine doses and ancillary supply kits under Operation Warp Speed, highlighting the company's long-standing role as major vaccine distributor in the United States (including its position as the largest distributor of the seasonal flu vaccine). The company has played a key role in distributing the Moderna and Johnson & Johnson vaccines while also distributing ancillary supply kits for these as well as for the Pfizer–BioNTech vaccine across the U.S. (in addition to supporting the U.S. government in efforts to send doses and kits abroad).
As of May 5, 2022, McKesson had distributed over 380 million vaccine doses and delivered supply kits to support over 1.2 billion vaccines doses throughout the United States.
In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services from Provigo. In 2002, the McKesson Canada name was adopted. McKesson Canada is a wholly owned subsidiary of McKesson Corporation. It includes various business units: McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions and McKesson Information Solutions.
In March 2016, McKesson agreed to purchase Canadian pharmacy chain Rexall from the Katz Group of Companies for $3 billion. The deal was finalized in December 2016 following approval received under the Investment Canada Act.
In May 2018, McKesson Canada closed 40 Rexall locations in Ontario and Western Canada.
In the United Kingdom, McKesson (operating as McKesson Information Solutions UK Ltd) was a provider of information technology services to the health care industry. In addition to numerous clinical software systems and finance and procurement services, McKesson also was responsible for developing the Electronic Staff Record system for the National Health Service which provided an integrated payroll system for NHS's 1.3 million staff, making it the world's largest single payroll IT system. McKesson Shared Services also provided payroll services for over 20 NHS Trusts, paying over 100,000 NHS members.
McKesson's United Kingdom base was in Warwick with data centers in Newcastle upon Tyne and Brent Cross and offices in Sheffield, Bangor, Glasgow and Vauxhall, London. Across the United Kingdom, it employed over 500 people.
In June/July 2014 McKesson sold most of their healthcare software business to the private equity firm Symphony Technology Group and indicated also that they would not be re-bidding for the Electronic Staff Record contract. This came after the company had posted significant year on year losses in revenue (16% in the 2012/13 financial year) after taking over a very successful British operation in 2011.
Australia and New Zealand
McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November 2012. McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand. The majority of the District Health Boards in NZ use one or more of McKesson's Capacity Management solutions.
Christchurch, New Zealand, is one of McKesson's global Capacity Management R&D centers of excellence. All of McKesson's R&D for McKesson Capacity Planner is performed in New Zealand. The company employs approximately 40 team members across Australia and New Zealand including general management, R&D, sales, services, and support employees.
McKesson Capacity Planner (formerly Emendo CapPlan) is used in more than 40 hospitals in Australia, New Zealand, Britain, Canada and the US to forecast future patient activity and help health systems to allocate resources efficiently and identify unnecessary costs.
On November 2, 2020, Walgreens Boots Alliance and McKesson Corporation announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA holds a 70 percent controlling equity interest in the joint venture and McKesson holds the remaining 30 percent interest.
In April 2012, McKesson agreed to pay the United States $190M to settle allegations that it had inflated prices and overbilled Medicaid.
In July 2012, McKesson agreed to pay California and 28 other states $151M to settle allegations that it had inflated prices and overbilled Medicaid.
In January 2017, McKesson agreed to pay $150M to settle allegations that it hadn't done enough to track and stop suspicious opioid sales. The agreement also obligated McKesson to suspend all sales of controlled substances from its distribution centres in Colorado, Ohio, Michigan, and Florida for multiple years.
- "Annual Report | Fiscal Year Ended March 31, 2022". U.S. Securities and Exchange Commission. May 9, 2022.
- Leggate, James (July 22, 2020). "What is McKesson?". FOXBusiness. Retrieved May 6, 2021.
- "McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results". McKesson Corp. Retrieved 10 December 2021.
- Mitchell, Luke (February 1, 2009). "Sick in the Head". Harper's Magazine. Archived from the original on May 25, 2017. Retrieved April 24, 2017.
- Terry, Mark. "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 10 December 2021.
- "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson Investor Relations. Retrieved May 5, 2021.
- "McKesson | 2021 Fortune 500". Fortune. Retrieved December 10, 2021.
- McKesson & Robbins, First Aid In Emergencies, 1930, p. 63.
- David Morrell (January 22, 2010). "San Francisco's McKesson: 'The largest company no one has heard of'". East Bay Times.
- [Everybody's Business 1st edition (Milton Moskowitz, Michael Katz, Robert Levering, editors) Harper & Row, 1980 page 815]
- "History of McKesson Corporation". mckesson.com. Archived from the original on April 24, 2015. Retrieved April 20, 2015.
- Ap (September 3, 1982). "Foremost Dairies". The New York Times. ISSN 0362-4331. Archived from the original on May 24, 2015. Retrieved March 10, 2019.
- Gomes, Lee (October 19, 1998). "McKesson Agrees to Acquire HBO & Co. for $14.46 Billion". Wall Street Journal. ISSN 0099-9660. Retrieved September 3, 2020.
- "Former executives of HBO & Co. indicted on accounting fraud charges - Sep. 28, 2000". CNN. September 28, 2000. Retrieved September 3, 2020.
- "McKesson Drops HBOC From Name". Los Angeles Times. July 26, 2001. Retrieved September 3, 2020.
- Milt Freudenheim (January 13, 2005). "McKesson Agrees to Pay $960 Million in Fraud Suit". The New York Times. Archived from the original on May 31, 2013. Retrieved March 17, 2008.
- "McKesson to acquire Per-Se Technologies". Los Angeles Times. November 7, 2006. Retrieved September 3, 2020.
- "McKesson acquires RelayHealth". Modern Healthcare. June 12, 2006. Retrieved September 3, 2020.
- "McKesson acquires Practice Partner". Modern Healthcare. February 28, 2007. Retrieved September 3, 2020.
- Whelan, David. "Why Did McKesson Buy U.S. Oncology?". Forbes. Retrieved September 3, 2020.
- Mark Maremont (June 25, 2013). "McKesson CEO Is Due $159 Million Pension". Wall Street Journal. Archived from the original on April 27, 2015. Retrieved April 20, 2015.
- "McKesson Launches Public Takeover Offer for Celesio | McKesson". www.mckesson.com. Archived from the original on August 7, 2018. Retrieved January 21, 2019.
- Kennedy, Eleanor (June 28, 2016). "Change Healthcare merger to create health IT giant". Nashville Business Journal.
- "Can big pharma stop the Arkansas mass executions?". The Guardian. April 16, 2017. Archived from the original on April 21, 2017. Retrieved April 21, 2017.
- Supplier: Drug sold to Arkansas not intended for executions Archived April 22, 2017, at the Wayback Machine | CBS News
- "McKesson, nation's sixth largest company, is moving corporate HQ from California to Irving". Dallas News. November 30, 2018. Archived from the original on December 4, 2018. Retrieved December 4, 2018.
- "Brian Tyler Becomes McKesson's New CEO - McKesson". www.mckesson.com. Archived from the original on April 12, 2019. Retrieved April 12, 2019.
- Schneider, Rob (December 6, 2019). "'Don't Debate It For 40 Years, Do It' Brian Tyler, McKesson". Dallas Business Journal.
- Stinnett, Joel (February 5, 2020). "Three years after merger, McKesson to part ways with Change Healthcare". Nashville Business Journal. Retrieved March 3, 2020.
- Raimonde, Olivia (Aug 14, 2020). "McKesson to Distribute Virus Vaccine Under Existing U.S. Pact". Bloomberg LP. Retrieved 10 December 2021.
- "Financial Information | McKesson Investor Relations". investor.mckesson.com. Archived from the original on January 14, 2019. Retrieved November 7, 2018.
- "Fortune 500 Companies 2018: Who Made the List". Fortune. Archived from the original on November 10, 2018. Retrieved November 9, 2018.
- McKesson Completes Acquisition of Medcon Ltd. | Business Wire Archived December 3, 2013, at the Wayback Machine August 15, 2005
- Burger, Ludwig (October 24, 2013). "McKesson $8.3 billion deal for drugs trader Celesio to create market leader". Reuters. Archived from the original on September 24, 2015. Retrieved July 1, 2017.
- "McKesson Medical Supplies and Equipment". Archived from the original on January 21, 2019. Retrieved March 1, 2018.
- Gilligan, Gregory J. "McKesson Medical-Surgical opens its new headquarters". Richmond Times-Dispatch. Retrieved January 12, 2018.
- "Health Mart Pharmacy of the Year Spotlight". healthmart.com.
- "McKesson Corp, Form 8-K, Current Report, Filing Date Nov 22, 1996". secdatabase.com. Archived from the original on April 24, 2018. Retrieved April 23, 2018.
- "The Stout Report: Eggs Florentine, Gavi and Breakfast with Gerald Asher". theblendblog.com. Archived from the original on June 1, 2013.
- "National Data Corp. changes name to NDCHealth Corp". Atlanta Business Chronicle. October 30, 2001. Retrieved June 24, 2020.
- "NDC started in 1967, and paralleled Rapidata". Bloomberg. Archived from the original on September 10, 2016.
- Bruce Bosworth, ISBN 978-089529-1-677
- Computerworld, October 6, 1986, p.179, "Rapidata revenue was $11 million ... in 1986, down from ... ($31 million in 1982)."
- Computerworld, Aug.25,1986, p.5, "National Data Corp. said it is close to reaching an agreement with a buyer of its Rapidata timesharing division. In May, National Data said it would close down ..."
- "Guide to Time Sharing" (PDF).
- Bill Whittaker (December 17, 2017). "Whistleblowers: DEA attorneys went easy on McKesson, the country's largest drug distributor". CBS News. Archived from the original on December 24, 2017. Retrieved December 24, 2017.
- "McKesson Corp, Form DEF 14A, Filing Date Jun 16, 2017" (PDF). SECdatabase.com. Archived (PDF) from the original on April 24, 2018. Retrieved April 23, 2018.
- "Attorney General Hunter Refiles Lawsuits against Three Leading Opioid Distributors | Oklahoma Attorney General". oag.ok.gov. Retrieved 2022-03-12.
- Raymond, Nate (2022-01-27). "Most U.S. local governments opt to join $26 bln opioid settlement". Reuters. Retrieved 2022-02-21.
- Raymond, Nate (2021-11-16). "Washington state, in $95 billion opioid trial, blames drug distributors for crisis". Reuters. Retrieved 2022-02-21.
- "When Flu Season and COVID-19 Collide". McKesson Corp. Retrieved 10 December 2021.
- "A Look Into Our COVID-19 Vaccine Ancillary Supply Kit Operation". McKesson Corp.
- Strauss, Marina (March 2, 2016). "Rexall takeover shakes up Canada's drugstore industry". The Globe and Mail. Archived from the original on August 26, 2017. Retrieved September 4, 2017.
- "McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada | McKesson Investor Relations". investor.mckesson.com. Archived from the original on January 21, 2019. Retrieved July 17, 2018.
- "Rexall closing after less than 5 years in London's downtown core". 980 CFPL. Archived from the original on July 17, 2018. Retrieved July 17, 2018.
- Jon Hoeksma (May 8, 2013). "McKesson UK put up for sale". ehiNEWS. Archived from the original on April 3, 2015. Retrieved March 26, 2015.
- Jon Hoeksma (June 2, 2014). "Symphony buys McKesson UK health ops". ehiNEWS. Archived from the original on April 2, 2015. Retrieved March 26, 2015.
- "Article: Symphony Technology Group snaps up McKesson divestments". HealthInvestor. Archived from the original on September 25, 2015. Retrieved January 2, 2016.
- "McKesson To Acquire British Software Vendor System C | HIStalk". Histalk2.com. March 3, 2011. Archived from the original on September 23, 2015. Retrieved January 2, 2016.
- Craft, Mark. "Aurelius Completes Acquisition Of LloydsPharmacy And AAH - KamCity". Retrieved 2022-04-08.
- "McKesson to Sell Its McKesson Asia-Pacific Business to Medibank Private Ltd". Archived from the original on April 13, 2016. Retrieved March 30, 2016.
- "Medibank finalises acquisition of McKesson Asia-Pacific". Archived from the original on April 8, 2016. Retrieved March 30, 2016.
- "McKesson NZ aims for growth with plans to add staff and products - Computerworld New Zealand". Computerworld.co.nz. May 23, 2014. Archived from the original on July 20, 2015. Retrieved July 30, 2015.
- Tamlyn Stewart (November 8, 2012). "Pharma giant snaps up Emendo". Stuff.co.nz. Archived from the original on September 24, 2015. Retrieved July 30, 2015.
- Tamlyn Stewart (November 7, 2012). "Fortune 500 firm buys Kiwi tech company". Stuff.co.nz. Archived from the original on September 24, 2015. Retrieved July 30, 2015.
- "Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture". Mckesson.com. November 2, 2020. Retrieved November 2, 2020.
- "Contact Us, Location Addresses & Phone Numbers - McKesson". www.mckesson.com. Archived from the original on September 13, 2018. Retrieved September 13, 2018.
- "McKesson Corp. Pays U.S. More Than $190 Million to Resolve False Claims Act Allegations". www.justice.gov. 2012-04-26. Retrieved 2022-02-21.
- "Attorney General Kamala D. Harris Recovers $23.5 Million in Settlement with McKesson Over Inflated Prescription Drug Prices". State of California - Department of Justice - Office of the Attorney General. 2012-07-26. Retrieved 2022-02-21.
- "McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs". www.justice.gov. 2017-01-17. Retrieved 2022-02-21.
- Official website
- Business data for McKesson Corporation: